The DOI matches its Crossref record.
Structure and Biology of Tissue Factor Pathway Inhibitor
Abstract
Summary: Human tissue factor pathway inhibitor (TFPI) is a modular protein comprised of three Kunitz type domains flanked by peptide segments that are less structured. The sequential order of the elements are: an N-terminal acidic region followed by the first Kunitz domain (K1), a linker region, a second Kunitz domain (K2), a second linker region, the third Kunitz domain (K3), and the C-terminal basic region. The K1 domain inhibits factor VIIa complexed to tissue factor (TF) while the K2 domain inhibits factor Xa. No direct protease inhibiting functions have been demonstrated for the K3 domain. Importantly, the Xa-TFPI complex is a much more potent inhibitor of the VIIa-TF than TFPI by itself. Furthermore, the C-terminal basic region of TFPI is required for rapid physiologic inhibition of coagulation and is needed for the inhibition of smooth muscle cell proliferation. Although a number of additional targets for attachment have been reported, the C-terminal basic region appears to play an important role in binding of TFPI to cell surfaces. A primary site of TFPI synthesis is endothelium and the endothelium-bound TFPI contributes to the antithrombotic potential of the vascular endothelium. Further, increased levels of plasma TFPI under septic conditions may represent endothelial dysfunction. We have proposed that the extravascular cells that synthesize TF also synthesize TFPI providing dual components necessary for the regulation of clotting in their microenvironment. Like the TF synthesis in these cells is augmented by serum, so is the case with the TFPI gene expression. TFPI gene knock out mice reveal embryonic lethality suggesting a possible role of this protein in early development. Since TF-induced coagulation is thought to play a significant role in many disease states, including disseminated intravascular clotting, sepsis, acute lung injury and cancer, recombinant TFPI may be a beneficial therapeutic agent in these disease states to attenuate pathologic clotting. The purpose of this review is to outline recent developments in the field related to the structural specificity and biology of TFPI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tripodi, A., Salerno, F., Chantarangkul, V., Clerici, M., Cazzaniga, M., Primignani, M., & Mannuccio Mannucci, P. (2005) · Hepatology · doi:10.1002/hep.20569 · Cited by 696
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
Tripodi, A., Primignani, M., Chantarangkul, V., Dell'Era, A., Clerici, M., de Franchis, R., Colombo, M., & Mannucci, P. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.045 · Cited by 547
Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis
Hassan, A. (2003) · Brain · doi:10.1093/brain/awg040 · Cited by 417
Thrombin Generation Assay and Its Application in the Clinical Laboratory
Tripodi, A. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.248625 · Cited by 318
Endothelial microparticles as markers of endothelial dysfunction
Horstman, L. (2004) · Frontiers in Bioscience · doi:10.2741/1270 · Cited by 300
Metadata
- Authors
- Birktoft, J., Steer, S., Bajaj, S. P., & Bajaj, M.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 86
- Issue
- 10
- Pages
- 959-972
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W4322702503
- Cited by
- 219
- References
- 0
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure and Biology of Tissue Factor Pathway Inhibitor. https://app.cochat.ai/papers/10.1055/s-0037-1616518
- The paper
- Birktoft, J., Steer, S., Bajaj, S. P., & Bajaj, M. (2001). Structure and Biology of Tissue Factor Pathway Inhibitor. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1616518
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.